SCA
CORT icon

Spearhead Capital Advisors’s Corcept Therapeutics CORT Stock Holding History

Spearhead Capital Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,876
Closed -$334K – 204
2021
Q4 		$334K Buy
16,876
+276
+2% +$5.6K 0.04% 139
2021
Q3 		$327K Sell
16,600
-92
-0.6% -$1.93K 0.04% 142
2021
Q2 		$367K Buy
16,692
+2,487
+18% +$55.3K 0.05% 157
2021
Q1 		$338K Sell
14,205
-3,643
-20% -$97.3K 0.05% 135
2020
Q4 		$467K Buy
17,848
+364
+2% +$7.67K 0.07% 103
2020
Q3 		$304K Buy
17,484
+1,147
+7% +$18.3K 0.06% 131
2020
Q2 		$275K Buy
16,337
+3,219
+25% +$45.2K 0.06% 117
2020
Q1 		$156K Buy
+13,118
New +$162K 0.05% 97

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return